Selumetinib in the treatment of type 1 neurofibromatosis in a child.

Author: Bang Tao LI ¹ ; Ge ZHANG ² ; Qi Ming PANG ¹ ; Yuan Ping HAI ¹ ; Sheng Cai WANG ² ; Qiao Yin LIU ² ; Yan SU ³ ; Jun ZOU ⁴ ; Jiao Yang LI ¹ ; Wei XIANG ⁵ ; Xin NI ²
Author Information

1. Center for Neuroscience, Hainan Women's and Children's Medical Center, Haikou 570206, China.
2. Department of Otorhinolaryngology Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China.
3. Department of Medical Oncology, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China.
4. Department of Pharmacy, Hainan Women's and Children's Medical Center, Haikou 570206, China.
5. Key Laboratory of Tropical Translation Medicine of Ministry of Education, Hainan Medical University, Haikou 570206, China.
Publication Type:Journal Article
MeSH: Humans; Child; Neurofibromatosis 1/drug therapy*; Benzimidazoles/therapeutic use*
From: Chinese Journal of Pediatrics 2023;61(10):938-940
CountryChina
Language:Chinese